The Antimicrobial Resistance Leadership Group (ARLG) (AAC ed.)

<p>ARLG is changing the field of clinical research in antimicrobial resistance. We will talk with the Principal Investigators of the ARLG to discuss their strategy</p> <p>Objectives:</p> <p>• Review the history and accomplishments of ARLG<br /> • Discuss the missions of ARLG including training new clinical investigators focused on antibiotic resistance<br /> • Comment of the future of ARLG and clinical research on antibiotic resistance</p> <p>Joining me to talk about ARLG are the principal investigators of this ambitious effort:</p> <p>• Dr. Vance Fowler: Professor of Medicine, Florence McAlister Distinguished Professor of Medicine, Professor in Molecular Genetics and Microbiology, Duke University.<br /> • Dr. Henry “Chip” Chambers: Professor of Medicine, Emeritus. University of California, San Francisco</p> <p>Visit aac.asm.org to read the current issue.</p>